Who owns PulseSight Therapeutics?

PulseSight Therapeutics is formerly owned by Karista, through CapDecisif 3, since 2017.

When did Karista acquire PulseSight Therapeutics?

Karista acquired PulseSight Therapeutics in 2017 and exited after 2 years.

Yes. PulseSight Therapeutics was exited in 2019 via MBO.

Home/Companies/Healthcare/PulseSight Therapeutics

Healthcare·

France·Exited 2019·Held 2yr

PulseSight Therapeutics is a healthcare company, headquartered in France.

Entry

2017

Hold

2yr

Exit

2019

Est. EV

–

Investor

HQFrance

SectorHealthcare

Gene therapy for retinal diseases; Karista CapDecisif 3 entered 2017 and exited 2019 MBO.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in CapDecisif 3

6 comparable healthcare deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Already a member? Sign in

Data refreshed weekly · Sourced from public filings